Teradyne (TER) Cash & Equivalents (2009 - 2026)

Teradyne has reported Cash & Equivalents for 18 years, with the latest figure at $241.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 49.13% year-over-year to $241.9 million; the trailing twelve-month figure through Mar 2026 stood at $241.9 million (down 49.13% YoY), and the FY2025 full-year result was $293.8 million, down 46.91% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $241.9 million, down from $293.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $854.8 million in Q4 2022, with the low at $241.9 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $553.2 million across 5 years, with a median of $572.0 million in 2022.
• Annual changes were most pronounced in 2024 — Cash & Equivalents climbed 8.96% — and 2026, when it plunged 49.13%.
• Teradyne's Cash & Equivalents stood at $854.8 million in 2022, then fell by 11.37% to $757.6 million in 2023, then retreated by 26.96% to $553.4 million in 2024, then tumbled by 46.91% to $293.8 million in 2025, then decreased by 17.64% to $241.9 million in 2026.
• The last three Cash & Equivalents figures came in at $241.9 million (Q1 2026), $293.8 million (Q4 2025), and $272.7 million (Q3 2025), per Business Quant data.